R. Voltan

发表

Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery

L. Prodi, E. Rampazzo, P. Secchiero, 2015, Expert opinion on drug delivery.

Actively targeted nanocarriers for drug delivery to cancer cells

P. Secchiero, G. Zauli, S. Biffi, 2019, Expert opinion on drug delivery.

Nanoparticles loaded with Nutlin-3 display cytotoxicity towards p53(wild-type) JVM-2 but not towards p53(mutated) BJAB leukemic cells.

P. Secchiero, G. Zauli, B. Ruozi, 2013, Current medicinal chemistry.

Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis.

L. Prodi, E. Rampazzo, P. Secchiero, 2013, Nanoscale.

Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging

L. Andolfi, L. Prodi, E. Rampazzo, 2014 .

Preparation and Characterization of Innovative Protein-coated Poly(Methylmethacrylate) Core-shell Nanoparticles for Vaccine Purposes

G. Altavilla, A. Caputo, B. Ensoli, 2007, Pharmaceutical Research.

Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration.

G. Altavilla, R. Gavioli, A. Caputo, 2009, Vaccine.

Rhesus Macaque Resistance to Mucosal Simian Immunodeficiency Virus Infection Is Associated with a Postentry Block in Viral Replication

D. Dimitrov, M. Robert-Guroff, S. Phogat, 2002, Journal of Virology.

Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents.

A. Gonelli, G. Zauli, S. Salvadori, 2009, Mini reviews in medicinal chemistry.

Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis

N. Basaglia, S. Straudi, P. Secchiero, 2018, Front. Neurol..

SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase.

M. Ronjat, L. Csernoch, S. Treves, 2012, The Biochemical journal.

Activation of the p53 pathway induces α‐smooth muscle actin expression in both myeloid leukemic cells and normal macrophages

P. Secchiero, A. Gonelli, G. Zauli, 2012, Journal of cellular physiology.

Human Cancer Biology miR-34 a Induces the Downregulation of Both E 2 F 1 and B-Myb Oncogenes in Leukemic Cells

M. Sana, P. Secchiero, G. Zauli, 2011 .

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation

P. Secchiero, G. Zauli, R. Voltan, 2022, Frontiers in Medicine.

Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model

G. Meroni, P. Secchiero, G. Zauli, 2014, PloS one.

Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines

G. Zauli, V. Gattei, E. Rimondi, 2011, Investigational New Drugs.

Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders.

G. Zauli, V. Tisato, R. Voltan, 2014, Frontiers in bioscience.

Anti-leukemic activity of Dasatinib in both p53wild-type and p53mutated B malignant cells

P. Secchiero, F. Corallini, S. Capitani, 2012, Investigational New Drugs.

Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors

P. Secchiero, G. Zauli, D. Milani, 2021, Current oncology.

Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia

A. Cuneo, P. Secchiero, G. Zauli, 2016, Oncotarget.

Perifosine plus nutlin‐3 combination shows a synergistic anti‐leukaemic activity

P. Secchiero, G. Zauli, R. Voltan, 2010, British journal of haematology.

The γ-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells

P. Secchiero, G. Zauli, V. Tisato, 2017, Oncotarget.

MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma

G. Zauli, R. Voltan, A. Romani, 2022, Frontiers in Oncology.

Clinical perspectives of TRAIL: insights into central nervous system disorders

P. Secchiero, A. Gonelli, G. Zauli, 2016, Cellular and Molecular Life Sciences.

Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells

P. Secchiero, G. Zauli, R. Rizzo, 2022, Frontiers in Pharmacology.

Expeditious Synthesis and Biological Characterization of Enantio‐Enriched (‐)‐Nutlin‐3

P. Secchiero, D. Milani, A. Cavazzini, 2017 .

HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts

P. Secchiero, G. Zauli, R. Rizzo, 2018, Scientific Reports.

Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis

M. Pedriali, F. Salvi, N. Basaglia, 2018, Molecular Medicine.

Activation of PKC-ε counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members

A. Gonelli, D. Milani, E. Rimondi, 2009, European journal of histochemistry : EJH.

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer

P. Secchiero, A. Gonelli, G. Zauli, 2017, Journal of Hematology & Oncology.

Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.

G. Altavilla, R. Gavioli, A. Caputo, 2009, Vaccine.

miR-34a Induces the Downregulation of Both E2F1 and B-Myb Oncogenes in Leukemic Cells

M. Sana, P. Secchiero, G. Zauli, 2011, Clinical Cancer Research.

Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.

W. Alvord, M. Robert-Guroff, B. Ensoli, 2005, Virology.

Endothelial Cells Obtained from Patients Affected by Chronic Venous Disease Exhibit a Pro-Inflammatory Phenotype

P. Secchiero, G. Zauli, P. Zamboni, 2012, PloS one.

Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application.

M. Marchisio, F. Nappi, A. Caputo, 2001, Vaccine.

The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status

F. Lanza, P. Secchiero, G. Zauli, 2012, Haematologica.

MCL1 down‐regulation plays a critical role in mediating the higher anti‐leukaemic activity of the multi‐kinase inhibitor Sorafenib with respect to Dasatinib

P. Secchiero, G. Zauli, R. Voltan, 2012, British journal of haematology.

The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.

R. Gavioli, A. Caputo, B. Ensoli, 2008, Vaccine.

Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells

M. Ferracin, P. Secchiero, A. Fucili, 2016, Journal of cellular physiology.

In Vitro Endothelial Cell Proliferation Assay Reveals Distinct Levels of Proangiogenic Cytokines Characterizing Sera of Healthy Subjects and of Patients with Heart Failure

R. Ferrari, P. Secchiero, G. Zauli, 2014, Mediators of inflammation.

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?

C. Cervellati, P. Secchiero, G. Zauli, 2019, Clinical science.

Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity.

P. Secchiero, G. Zauli, D. Milani, 2016, The international journal of biochemistry & cell biology.

Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity

W. Alvord, M. Robert-Guroff, Qifeng Zhou, 2006, AIDS.

The Oncogene DEK Promotes Leukemic Cell Survival and Is Downregulated by both Nutlin-3 and Chlorambucil in B-Chronic Lymphocytic Leukemic Cells

P. Secchiero, G. Zauli, M. Tiribelli, 2010, Clinical Cancer Research.

Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo

F. Corallini, B. Fabris, R. Candido, 2009, Journal of Vascular Research.

Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease

S. Volpato, P. Secchiero, G. Zauli, 2018, PloS one.

Clinical perspectives of TRAIL: insights into central nervous system disorders

P. Secchiero, A. Gonelli, G. Zauli, 2016, Cellular and Molecular Life Sciences.

Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1

P. Secchiero, G. Zauli, V. Bertolasi, 2016, Oncotarget.

Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity.

P. Secchiero, G. Zauli, S. Salvadori, 2016, Journal of medicinal chemistry.

The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias

D. Vozzi, A. Cuneo, P. Secchiero, 2014, Oncotarget.

Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples

R. Voltan, M. G. di Iasio, O. Radillo, 2012, Investigational New Drugs.

Nutlin-3 Downregulates the Expression of the Oncogene TCL1 in Primary B Chronic Lymphocytic Leukemic Cells

P. Secchiero, G. Zauli, N. Valeri, 2011, Clinical Cancer Research.

Cancer Therapy : Preclinical Nutlin-3 Downregulates the Expression of the Oncogene TCL 1 in Primary B Chronic Lymphocytic Leukemic Cells

P. Secchiero, G. Zauli, N. Valeri, 2011 .

Cancer Therapy : Preclinical Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p 53 wild-type and p 53 mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway

A. Cuneo, P. Secchiero, G. Zauli, 2011 .

Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway

A. Cuneo, P. Secchiero, G. Zauli, 2010, Clinical Cancer Research.

DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination.

Giuseppe Altavilla, Marco Ballestri, Antonella Caputo, 2006, Vaccine.

Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.

R. Gavioli, A. Caputo, B. Ensoli, 2008, Vaccine.

Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts

P. Secchiero, G. Zauli, B. Ruozi, 2013, Clinical Cancer Research.

Running title: Rituximab plus Nutlin-3 loaded nanoparticles

P. Secchiero, G. Zauli, B. Ruozi, 2013 .

Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis

M. Pedriali, F. Salvi, N. Basaglia, 2018, Molecular medicine.

Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection

M. Previati, D. Sergi, R. Voltan, 2023, Frontiers in Nutrition.

The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia

P. Secchiero, G. Zauli, V. Gattei, 2010, Leukemia.

State of the art of the therapeutic perspective of sorafenib against hematological malignancies.

P. Secchiero, G. Zauli, V. Tisato, 2012, Current medicinal chemistry.

Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells

P. Secchiero, A. Maietti, N. Marchetti, 2021, Molecules.

HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts

P. Secchiero, G. Zauli, R. Rizzo, 2018, Scientific Reports.

Live recombinant vectors for AIDS vaccine development.

M. Robert-Guroff, R. Voltan, 2003, Current molecular medicine.

Selective induction of TP53I3/p53‐inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin‐3

P. Secchiero, F. Corallini, G. Zauli, 2014, Molecular carcinogenesis.

Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells

M. Ferracin, P. Secchiero, A. Fucili, 2016, Journal of cellular physiology.

Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.

G. Altavilla, R. Gavioli, A. Caputo, 2009, Vaccine.